db-opentargets

To identify druggable therapeutic targets, you query target-disease associations and assess druggability using genetic, clinical, and literature evidence. This approach integrates biomedical datasets to pinpoint genes strongly associated with your disease.

The best way to find drugs for repurposing is to retrieve known drug interactions for your target genes and evaluate their disease associations. This allows you to identify existing drugs that could be effective for new indications.

Yes, you can assess safety liabilities and biological relevance programmatically. By querying comprehensive target-disease association data, you can validate a gene's druggability and safety profile to ensure its suitability for drug discovery workflows.

Accessing pharmacology and biomedical data programmatically requires the requests dependency to interface with the API. This setup facilitates retrieving gene annotations, disease information, and known drug interactions.

To validate a gene's therapeutic potential, you retrieve data on its druggability, safety liabilities, and genetic evidence. This process supports therapeutic target validation by integrating diverse biological and clinical datasets.